Organic & Biomolecular Chemistry · 2015 · 15 citations · 27 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryEnzymologyAntifungal PharmacologyDrug-target Interaction MappingEnzyme InhibitionTopoisomerase InhibitorsAntibacterial PropertiesDna Topoisomerase Ii InhibitionRational PolypharmacologySecondary MetabolitesTopoisomerase ActivityTopoisomerase Ii FunctionTopoisomerase Ii InhibitorsTopoisomerase Targets
The jadomycins are a family of secondary metabolites produced by S. venezuelae ISP5230. Specific jadomycins have been shown to possess a variety of anticancer, antifungal, and antibacterial properties, with different molecular mechanisms of action. Herein we demonstrate qualitative and quantitative direct binding between the validated anticancer target human topoisomerase IIβ and jadomycin DS using WaterLOGSY NMR spectroscopy. Additionally, we report for the first time, that jadomycin DS also binds a variety of other proteins, likely in a non-specific manner. Such interactions may rationalize the potential polypharmacology of jadomycin DS.
27
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Chyuan-Chuan Wu, Tsai‐Kun Li, Lynn Farh et al. · Science · 2011 · 514 citations
Discovery of Unique Lanthionine Synthetases Reveals New Mechanistic and Evolutionary Insights
Yuki Goto, Jan Claesen, Yanxiang Shi et al. · PLoS Biology · 2010 · 224 citations · Full text
On the origins of drug polypharmacology
Xavier Jalencas, Jordi Mestres · MedChemComm · 2012 · 143 citations